Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 1,846,000 | 1,873,000 | 1,774,000 | 1,838,000 | 1,735,000 |
| Cost of Goods | 550,000 | 563,000 | 537,000 | 556,000 | 510,000 |
| Gross Profit | 1,296,000 | 1,310,000 | 1,237,000 | 1,282,000 | 1,225,000 |
| Operating Expenses | 1,232,000 | 1,379,000 | 1,040,000 | 1,155,000 | 1,122,000 |
| Operating Income | 64,000 | -69,000 | 197,000 | 127,000 | 103,000 |
| Interest Expense | 54,000 | 53,000 | 54,000 | 57,000 | 137,000 |
| Other Income | -7,000 | 18,000 | 3,000 | -11,000 | -6,000 |
| Pre-tax Income | 3,000 | -104,000 | 146,000 | 59,000 | -40,000 |
| Income Tax | -40,000 | -108,000 | 13,000 | -49,000 | -35,000 |
| Net Income Continuous | 43,000 | 4,000 | 133,000 | 108,000 | -5,000 |
| Net Income | $43,000 | $4,000 | $133,000 | $108,000 | $-5,000 |
| EPS Basic Total Ops | 0.03 | 0.00 | 0.10 | 0.07 | 0.00 |
| EPS Basic Continuous Ops | 0.03 | 0.00 | 0.10 | 0.08 | 0.00 |
| EPS Diluted Total Ops | 0.03 | 0.00 | 0.10 | 0.07 | 0.00 |
| EPS Diluted Continuous Ops | 0.03 | 0.00 | 0.10 | 0.08 | 0.00 |
| EBITDA(a) | $64,000 | $-69,000 | $197,000 | $127,000 | $103,000 |